BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 12407439)

  • 21. Tumor cell prothrombotic properties.
    Falanga A
    Haemostasis; 2001; 31 Suppl 1():1-4. PubMed ID: 11990464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathological haemostasis and "prothrombotic state" in Behçet's disease.
    Kiraz S; Ertenli I; Oztürk MA; Haznedaroğlu IC; Celik I; Calgüneri M
    Thromb Res; 2002 Jan; 105(2):125-33. PubMed ID: 11958802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer and the prothrombotic state.
    Lip GY; Chin BS; Blann AD
    Lancet Oncol; 2002 Jan; 3(1):27-34. PubMed ID: 11908507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin in tumor progression and metastatic dissemination.
    Falanga A; Marchetti M
    Semin Thromb Hemost; 2007 Oct; 33(7):688-94. PubMed ID: 18000796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypercoagulable states.
    Anderson JA; Weitz JI
    Crit Care Clin; 2011 Oct; 27(4):933-52, vii. PubMed ID: 22082521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer Tissue Procoagulant Mechanisms and the Hypercoagulable State of Patients with Cancer.
    Falanga A; Schieppati F; Russo D
    Semin Thromb Hemost; 2015 Oct; 41(7):756-64. PubMed ID: 26408922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microparticles and cancer.
    Amin C; Mackman N; Key NS
    Pathophysiol Haemost Thromb; 2008; 36(3-4):177-83. PubMed ID: 19176990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenetic mechanisms of thrombosis in malignancy.
    Donati MB; Falanga A
    Acta Haematol; 2001; 106(1-2):18-24. PubMed ID: 11549773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology.
    Winter PC
    Hematol Oncol; 2006 Sep; 24(3):126-33. PubMed ID: 16783843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hypercoagulable states.
    Schafer AI
    Ann Intern Med; 1985 Jun; 102(6):814-28. PubMed ID: 3158262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Blood coagulation changes and neoplastic pathology].
    Corsi MP; De Martinis M; Di Leonardo G; Loreto MF; Modesti M; Quaglino D
    Recenti Prog Med; 2000 Oct; 91(10):532-7. PubMed ID: 11072743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquired thrombophilic syndromes.
    Matei D; Brenner B; Marder VJ
    Blood Rev; 2001 Mar; 15(1):31-48. PubMed ID: 11333137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous thromboembolism and cancer: new issues for an old topic.
    Mandalà M; Ferretti G; Cremonesi M; Cazzaniga M; Curigliano G; Barni S
    Crit Rev Oncol Hematol; 2003 Oct; 48(1):65-80. PubMed ID: 14585484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coagulopathic complications in breast cancer.
    Caine GJ; Stonelake PS; Rea D; Lip GY
    Cancer; 2003 Oct; 98(8):1578-86. PubMed ID: 14534872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on tumor cell procoagulant factors.
    Gale AJ; Gordon SG
    Acta Haematol; 2001; 106(1-2):25-32. PubMed ID: 11549774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombosis in multiple myeloma.
    Zangari M; Elice F; Fink L; Tricot G
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):307-15. PubMed ID: 17338651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Disorders of hemostatic system in patients with malignant disease, especially in view of venous thromboembolism].
    Bozóky G; Ruby E; Góhér I; Mohos A; Bálint C; Bozóky I
    Orv Hetil; 2007 Sep; 148(36):1691-7. PubMed ID: 17766220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procoagulant role of neutrophil extracellular traps in patients with gastric cancer.
    Yang C; Sun W; Cui W; Li X; Yao J; Jia X; Li C; Wu H; Hu Z; Zou X
    Int J Clin Exp Pathol; 2015; 8(11):14075-86. PubMed ID: 26823721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphatidylserine-exposing tumor-derived microparticles exacerbate coagulation and cancer cell transendothelial migration in triple-negative breast cancer.
    Zhang C; Yang Z; Zhou P; Yu M; Li B; Liu Y; Jin J; Liu W; Jing H; Du J; Tian J; Zhao Z; Wang J; Chu Y; Zhang C; Novakovic VA; Shi J; Wu C
    Theranostics; 2021; 11(13):6445-6460. PubMed ID: 33995667
    [No Abstract]   [Full Text] [Related]  

  • 40. Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia.
    Walenga JM; Jeske WP; Messmore HL
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():13-20. PubMed ID: 11155190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.